This might indicate that the virus-targeting FBP, binding to viral proteins, could more effectively inhibit pH-dependent virus replication in vivo compared with the host-targeting chloroquine although both of them could inhibit the endocytic pathway of viral infection. This evidence concerns the gene FBP1 and viral infectious disease.